Pituitary tumorigenesis in prolactin gene-disrupted mice

Endocrinology

Volumn 143, Issue 11, 2002, Pages 4429-4436

  Cruz Soto, Martha E ^a   Scheiber, Michael D ^a   Gregerson, Karen A ^d   Boivin, Gregory P ^b,c   Horseman, Nelson D ^a  

^a Department of Obstetrics and Gynecology ^*  (United States)

^b Laboratory Medicine   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; GENE PRODUCT; PROLACTIN; PROTEIN KO 10; UNCLASSIFIED DRUG;

AGED; AMINO TERMINAL SEQUENCE; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL GRANULE; CELL HYPERPLASIA; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOPLASM; DISEASE MODEL; ENDOPLASMIC RETICULUM; FEEDBACK SYSTEM; FEMALE; GENE DISRUPTION; GENE TARGETING; HISTOPATHOLOGY; HYPERPLASIA; HYPERTROPHY; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IMMUNOREACTIVITY; KNOCKOUT GENE; MOUSE; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; PRL GENE; PROLACTIN RELEASE; REGULATORY MECHANISM;

EID: 0036827922     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220173     Document Type: Article

References (40)

1. Ben-Jonathan N 1985 Dopamine: A prolactin-inhibiting hormone. Endocr Rev 6:564-589
2. Bjorklund A, Moore RY, Nobin A, Stenevi U 1973 Organization of tuberohypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain. Brain Res 51:171-191
3. Wood D, Johnston J, Johnston D 1991 Dopamine, the dopamine receptor and pituitary tumors. Clin Endocrinol (Oxf) 35:445-466
4. Gregerson KA, Flagg TP, O'Neill TJ, Anderson M, Lauring O, Horel JS, Welling PA 2001 Identification of G protein-coupled, inward rectifier potassium channel gene products from the rat anterior pituitary gland. Endocrinology 142:2820-2832
5. Gudelsky G, Porter J 1980 Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration. Endocrinology 106:526-529
6. Perkins N, Westfall T, Paul C, McLeod R, Rogol A 1979 Effect of prolactin on dopamine synthesis in medial basal hypothalamus: Evidence for short-loop feedback. Brain Res 160:431-444
7. Romero M, Phelps C 1993 Prolactin replacement during development prevents the dopaminergic deficit in hypothalamic arcuate nucleus in prolactin-deficient Ames dwarf mice. Endocrinology 133:1860-1870
8. Arbogast L, Voogt J 1991 Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta. Endocrinology 128:997-1005
9. Burrow G, Wortzman G, Rewcastle N, Holgate R, Kovacs K 1981 Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 304:156-158
10. Elster A 1993 Modern imaging of the pituitary. Radiology 187:1-14
11. Asa SL, Ezzat S 1998 The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798-827
12. Kelly M, Rubinstein M, Asa S, Zhang G, Saez C, Bunzow J, Allen R, Hnasko R, Ben-Jonathan N, Grandy D, Low M 1997 Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19:103-113
13. 2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19:115-126
14. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926-6935
15. Steger RW, Chandrashekar V, Zhao W, Bartke A, Horseman ND 1998 Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139:3691-3695
16. Carson F 1997 Histotechnology: A Self-Instructional Text. 2nd Ed. Chicago: ASCP Press
17. Pratt SL, Horseman ND 1998 Identification of two Y-box binding proteins that interact with the promoters of columbid annexin I genes. Gene 214:147-156
18. Morin A, Picart R, Tixier-Vidal A 1996 Effects of the N-terminal cysteine mutation on prolactin expression and secretion in transfected cells. Mol Cell Endocrinol 117:59-73
19. Clement-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V, Bouchard B, Amling M, Gaillard-Kelly M, Binart N, Baron R, Kelly PA 1999 Osteoblasts are a new target for prolactin: Analysis of bone formation in prolactin receptor knockout mice. Endocrinology 140:96-105
20. Pei L, Melmed S 1997 Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433-441
21. Vomachka AJ, Pratt SL, Lockefeer JA, Horseman ND 2000 Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth. Oncogene 19:1077-1084
22. Bern HA, Nicoll CS 1968 The comparative endocrinology of prolactin. Recent Prog Horm Res 24:681-720
23. Horseman ND, Yu-Lee L-y 1994 Transcriptional regulation by the helix bundle peptide hormones: GH, PRL, and hematopoietic cytokines. Endocr Rev 15: 627-649
24. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268
25. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babomet C, Binart N, Kelly PA 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11:167-178
26. Dorshkind K, Horseman ND 2000 The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev 21:292-312
27. Dorshkind K, Horseman ND 2001 Anterior pituitary hormones, stress, and immune system homeostasis. BioEssays 23:288-294
28. Gomez-Dumm CL, Souto M, Estivariz FE, Moreno FR 1983 Prolactin secretion in normal male mice during a circadian period. An ultrastructural and biochemical study. Acta Anat 115:212-219
29. Cohen-Becker IR, Selmanoff M, Wise PM 1986 Hyperprolactinemia alters the frequency and amplitude of pulsatil luteinizing hormone secretion in the ovariectomized rat. Neuroendocrinology 42:328-333
30. Krasnow JS, Hickey GJ, Richards JS 1990 Regulation of aromatase mRNA and estradiol biosynthesis in rat ovarian granulosa and luteal cells by prolactin. Mol Endocrinol 4:13-21
31. Hyde JF, Moore Jr JP, Cai A 1998 Galanin in normal and hyperplastic anterior pituitary cells. From pituitary tumor cell lines to transgenic mice. Ann NY Acad Sci 863:48-55
32. Wynick D, Small CJ, Bacon A, Holmes FE, Norman M, Ormandy CJ, Kilic E, Kerr NC, Ghatei M, Talamantes F, Bloom SR, Pachnis V 1998 Galanin regulates prolactin release and lactotroph proliferation. Proc Natl Acad Sci USA 95:12671-12676
33. Lerant A, Freeman ME 1998 Ovarian steroids differentially regulate the expression of PRL-R in neuroendocrine dopaminergic neuron populations: A double label confocal microscopic study. Brain Res 802:141-154
34. Romero MI, Phelps CJ 1995 Prolactin replacement in adult dwarf mice does not reverse the deficit in tuberoinfundibular dopaminergic neuron number. Endocrinology 136:3238-3246
35. Phelps CJ, Horseman ND 2000 Prolactin gene disruption does not compromise differentiation of tuberoinfundibular dopammergic neurons. Neuroendocrinology 72:2-10
36. Pahl HL, Baeuerle PA 1997 The ER-overload response: Activation of NF-κB. Trends Biochem Sci 22:63-67
37. Ben-Jonathan N 1994 Regulation of prolactin secretion. In: Imura H, ed. The Pituitary Gland. 2nd Ed. New York: Raven Press; 261-283
38. Saeger W 1992 Effect of drugs on pituitary ultrastructure. Microsc Res Technol 20:162-176
39. Schottke H, Saeger W 1986 Ultrastructural morphology of prolactin secreting adenomas treated with dopamine agonists. Pathol Res Pract 181:280-290
40. Krown KA, Wang Y-F, Ho TWC, Kelly PA, Walker AM 1992 Prolactin isoform 2 as an autocrine growth factor for GH3 cells. Endocrinology 131:595-602